Covalis Capital’s M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant MBAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-333,331
Closed -$1.69M 137
2021
Q3
$1.69M Sell
333,331
-305,421
-48% -$3.09M 0.39% 45
2021
Q2
$6.45M Sell
638,752
-361,248
-36% -$3.6M 2.09% 15
2021
Q1
$9.92M Buy
+1,000,000
New +$9.97M 2.04% 16

Other funds holding MBAC.U

Covalis Capital's MBAC.U Position: Q4 2021 in Review

Covalis Capital sold out of M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant (MBAC.U) in Q4 2021, closing a stake of 333,331 shares — an estimated $1.69M sold.

Covalis Capital first reported a position in MBAC.U in Q1 2021 and held it in 3 quarters. The position peaked at $9.92M in Q1 2021. 16 funds tracked by Wall St. Rank hold MBAC.U as of Q4 2021.

  • Covalis Capital reported no remaining M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Covalis Capital sold 333,331 M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant shares in Q4 2021, an estimated $1.69M.
  • Covalis Capital first reported a position in M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Covalis Capital's M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position peaked at $9.92M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant as of Q4 2021.

Based on Covalis Capital's 13F filing for Q4 2021, filed 14 Feb 2022.